Published in TB and Outbreaks Week, November 13th, 2001
"The optimal duration of tuberculosis treatment for persons infected with human immunodeficiency virus (HIV) has been debated," according to Cynthia R. Driver and colleagues working with the New York City Department of Health Tuberculosis Control Program.
Coinfected patients should receive longer treatment regimens or be checked regularly for tuberculosis recurrence, they say.
Driver and coworkers evaluated therapy outcomes in 4571 patients who were treated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.